<< Researchers succeed in engineering human tissue patches from stem cells | Cancer Genome Atlas funds study for analysis and interpretation of tumor genetic data >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

AGA Medical's patent on occlusion devices upheld

Published on October 8, 2009 at 2:53 AM · No Comments

AGA Medical Holdings, Inc. (AGA Medical) today announced that a five-judge panel in the German Federal Patent Court in Munich has upheld the validity of an important AGA Medical patent. The court rejected a lawsuit brought by Occlutech GmbH that contended that AGA Medical's patent did not meet the standards of patentability under German law. While the ruling is open to appeal, it is effective now. The patent (EP 0 808 138 B1) pertains to AGA Medical's occlusion devices and the manufacturing process.

AGA Medical is a leading developer of interventional devices for the minimally invasive treatment of cardiovascular defects and peripheral vascular disease. In December 2008, a German appeals court ruled in favor of AGA Medical in a patent infringement proceeding against Occlutech GmbH, headquartered in Jena, Germany. Although Occlutech has filed a request to appeal the infringement decision, the decision and the injunction against Occlutech remain in force. AGA Medical has now prevailed against Occlutech in two different branches of German courts and won cases with respect to both patent validity and infringement.

Source: AGA Medical

Posted in: Medical Patent News

Tags:

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading